Total Payments
$6,463
2024 Payments
$1,046
Companies
32
Transactions
461
Medicare Patients
37
Medicare Billing
$10,070
Payment Breakdown by Category
Food & Beverage$6,434 (99.6%)
Education$28.72 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,434 | 456 | 99.6% |
| Education | $28.72 | 5 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Corium, LLC | $1,293 | 83 | $0 (2024) |
| Neos Therapeutics, LP | $697.02 | 47 | $0 (2024) |
| Allergan, Inc. | $401.81 | 38 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $369.16 | 23 | $0 (2024) |
| Rhodes Pharmaceuticals L.P. | $349.01 | 46 | $0 (2019) |
| Shire North American Group Inc | $332.36 | 32 | $0 (2019) |
| Vanda Pharmaceuticals Inc. | $266.45 | 16 | $0 (2024) |
| Tris Pharma Inc | $260.60 | 15 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $256.74 | 12 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $255.21 | 28 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,046 | 58 | Corium, LLC ($447.45) |
| 2023 | $948.19 | 57 | Corium, LLC ($445.22) |
| 2022 | $877.95 | 54 | Corium, LLC ($361.36) |
| 2021 | $160.11 | 11 | Takeda Pharmaceuticals U.S.A., Inc. ($50.87) |
| 2020 | $462.42 | 25 | Tris Pharma Inc ($69.83) |
| 2019 | $1,202 | 89 | Neos Therapeutics, LP ($208.19) |
| 2018 | $1,070 | 105 | Sunovion Pharmaceuticals Inc. ($194.40) |
| 2017 | $696.50 | 62 | Neos Therapeutics, LP ($140.43) |
All Payment Transactions
461 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 12/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Neuropsychiatry | ||||||
| 11/21/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $29.08 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/14/2024 | Tris Pharma Inc | Onyda XR (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: ADHD | ||||||
| 11/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/29/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $29.69 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/24/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Neuropsychiatry | ||||||
| 10/22/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/15/2024 | Tris Pharma Inc | Onyda XR (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: ADHD | ||||||
| 10/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: PSYCHIATRY | ||||||
| 10/03/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $20.03 | General |
| Category: ADHD | ||||||
| 09/24/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/10/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/29/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: SCHIZOPHRENIA | ||||||
| 08/27/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/22/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: ADHD | ||||||
| 08/21/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Central Nervous System | ||||||
| 08/15/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Neuropsychiatry | ||||||
| 08/15/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $0.69 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 07/23/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Neuroscience | ||||||
| 07/22/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 07/22/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: ADHD | ||||||
| 07/22/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $3.10 | General |
| Category: CNS Stimulant for ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 12 | 29 | $4,437 | $2,392 |
| 2022 | 1 | 12 | 35 | $5,355 | $3,030 |
| 2021 | 1 | 13 | 52 | $7,956 | $4,648 |
Total Patients
37
Total Services
116
Medicare Billing
$10,070
Procedure Codes
3
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 29 | $4,437 | $2,392 | 53.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 35 | $5,355 | $3,030 | 56.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 52 | $7,956 | $4,648 | 58.4% |
About Dr. Robin Park, MD
Dr. Robin Park, MD is a Psychiatry healthcare provider based in Creve Coeur, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407871213.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robin Park, MD has received a total of $6,463 in payments from pharmaceutical and medical device companies, with $1,046 received in 2024. These payments were reported across 461 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($6,434).
As a Medicare-enrolled provider, Park has provided services to 37 Medicare beneficiaries, totaling 116 services with total Medicare billing of $10,070. Data is available for 3 years (2021–2023), covering 3 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Creve Coeur, MO
- Active Since 07/13/2006
- Last Updated 03/22/2013
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1407871213
Products in Payments
- Azstarys (Drug) $931.50
- Adzenys XR-ODT (Drug) $697.02
- VRAYLAR (Drug) $464.64
- AZSTARYS (Drug) $361.36
- Aptensio XR (Drug) $349.01
- REXULTI (Drug) $341.60
- VYVANSE (Drug) $268.44
- INGREZZA (Drug) $256.74
- LATUDA (Drug) $255.21
- Dyanavel XR (Drug) $211.59
- JORNAY PM (Drug) $197.62
- NUEDEXTA (Drug) $181.77
- SPRAVATO (Drug) $154.87
- Fanapt (Drug) $134.05
- Trintellix (Drug) $131.57
- QELBREE (Drug) $112.88
- MYDAYIS (Drug) $107.04
- ABILIFY MAINTENA (Drug) $101.43
- HETLIOZ (Drug) $97.93
- CAPLYTA (Drug) $80.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.